Show the Working

Reduce Health Inequalities and Prioritise Women's Health

Labour · what the evidence says

An independent, source-checked look at Labour’s policy “Reduce Health Inequalities and Prioritise Women's Health” — what it would actually do across the things that affect your life. Every claim below quotes the source behind it. How this works.

Inequality & fair shares — Helps

minor · low confidence

This policy directly targets the regional health inequality gap — a core O14 indicator — with some concrete instruments, but the gap has been widening for years and experts doubt the halving target is achievable by 2035. Real improvements are plausible but likely modest.

The evidence

Biggest unknown: Whether the concrete instruments (HIV funding, women's health strategy, social determinants agenda) are sufficient to reverse a decade-long widening trend in healthy life expectancy inequality between deprived and affluent areas.

Our reading: O14 is concerned with the gap between the richest and the rest, including regional inequality. The healthy life expectancy gap between the most and least deprived areas — currently ~19–20 years and widening over the past decade — is a direct and material O14 indicator. A policy explicitly targeting that gap therefore points toward 'improves' in direction. The policy is not purely aspirational: it is backed by concrete instruments (a funded HIV action plan, a relaunched Women's Health Strategy with 117 actions, social determinants interventions including employment rights and social housing). These instruments are targeted primarily at deprived and marginalised populations, which is redistributive in health terms and consistent with narrowing the gap. However, the magnitude and confidence must be kept low. The trend has been moving in the wrong direction for over a decade, with the gap growing by over 20% since 2011. Independent assessors — including the Health Foundation and Health Equals — suggest the halving target looks distant or unachievable on current trajectories. The HIV plan similarly faces enormous headwinds. The women's health component addresses disparities (racial bias, gynaecology waiting times, cardiovascular outcomes for women) that compound deprivation-linked inequality, but parliamentary scrutiny flags real delivery risks. Absent the policy, the gap would likely continue widening based on the established trend; the policy at minimum applies counterpressure with real mechanisms. But the gap between stated ambition and plausible delivery is large. The verdict is 'improves' at minor magnitude over a long-term horizon, with low confidence — reflecting that direction of travel is right but the scale of effect is highly uncertain and dependent on sustained implementation of instruments that have so far not reversed the trend.

Healthcare — Helps

moderate · moderate confidence

This policy targets major health inequalities, women's health gaps, and HIV elimination — all real problems backed by evidence. But ambitious targets like halving the healthy life expectancy gap have historically proved very hard to hit, and delivery depends on many factors beyond NHS reform alone.

The evidence

Biggest unknown: Whether tackling social determinants (poverty, housing, employment) will be implemented with sufficient scale and funding to materially close the 19–20 year healthy life expectancy gap, given that the gap has been widening, not narrowing.

Our reading: The policy addresses three areas where evidence shows genuine, large unmet need: a 19–20 year healthy life expectancy gap that is widening not narrowing; systematic under-prioritisation of women's health (decade-long diagnosis waits, cardiovascular mortality gaps, long gynaecology queues); and ongoing HIV transmission with thousands undiagnosed. These are real O3 problems. On health inequalities, the direction of stated ambition is right, but the trend has moved the wrong way for over a decade, and expert bodies (Health Equals, the Health Foundation) warn the target looks harder to hit than ever. The social determinants approach is evidence-based but requires cross-government delivery well beyond NHS reform. On women's health, the government has relaunched a strategy with 117 actions, but the Women and Equalities Committee warns it will be inadequate without embedding specific priorities — and there is a risk successful pilots (women's health hubs) get scaled back. On HIV, a funded action plan exists, but HIV i-Base judges the 2030 eradication target very difficult given flat new-diagnosis rates over 15 years. Overall, the policy's direction is clearly improvement-oriented and targets areas of genuine healthcare need. The ambition is credible in intent, and some specific actions (community diagnostics, HIV testing scale-up, women's health hubs) have demonstrated results. However, the scale of stated goals relative to current trends, delivery risks, and dependence on social policy levers outside the NHS justify moderate rather than major magnitude, and long-term rather than immediate time horizon.